Results 271 to 280 of about 120,291 (395)

Modeling the phenotype of spinal muscular atrophy by the direct conversion of human fibroblasts to motor neurons

open access: diamond, 2017
Qi‐Jie Zhang   +9 more
openalex   +2 more sources

Physiologically‐Based Pharmacokinetic Modeling to Support Pediatric Clinical Development: An IQ Working Group Perspective on the Current Status and Challenges

open access: yesCPT: Pharmacometrics &Systems Pharmacology, EarlyView.
ABSTRACT Pediatric extrapolation strategies issued by health authorities have streamlined pediatric drug development and reduced the unnecessary burden of conducting pediatric clinical studies. In line with these strategies, physiologically based pharmacokinetic (PBPK) models have been utilized extensively for initial dosing regimen and sampling ...
James W. T. Yates   +26 more
wiley   +1 more source

Micropatterned Surfaces with Unidirectional Wetting Properties for Liquid Transport

open access: yesSmall Structures, EarlyView.
Micropatterned surfaces that guide droplets in a single direction are gaining attention for their role in liquid transport. This review explores how surface designs enable such behavior, from gravity‐driven flow to stimulus‐responsive movement. It also discusses fabrication techniques, design challenges, and emerging strategies to advance directional ...
Elham Lori Zoudani   +5 more
wiley   +1 more source

Clinical Characteristics of Cases with Spinal Muscular Atrophy

open access: hybrid, 2016
Mehmet Canpolat   +6 more
openalex   +1 more source

Screening for spinal muscular atrophy

open access: yesMedical Journal of Australia, 2018
Sampaio, H, Wilcken, B, Farrar, M
openaire   +3 more sources

Review of published research on primary dysautonomia of domestic animals

open access: yesVeterinary Record, EarlyView.
Abstract An article published in 1992 by Marion M. Pollin and I.R. Griffiths reviewed the topic of primary dysautonomias of the autonomic nervous system of unidentified origin in multiple domestic species, specifically cats, dogs and horses. Thirty‐one years later, we appear no closer to identifying the causal agents of these strikingly similar ...
Tanith Harte   +3 more
wiley   +1 more source

Drug Candidate BIO101 for Spinal Muscular Atrophy as Monotherapy or Combined With the Antisense Oligonucleotide ASO-10-27. [PDF]

open access: yesJ Cachexia Sarcopenia Muscle
Bézier C   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy